This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Ghana

  1. In 2020, Ghana switched from using ROTARIX® to ROTAVAC® in its national immunization program. PATH worked with Ghana Health Service and the University of Ghana to analyze the economic implications of this switch. These four fact sheets explore the key results of these analyses, collectively providing a case study on Ghana’s rotavirus vaccine product switch.(Manuscript pending submission to a peer-reviewed journal.)
    Published: May 2022
    Type: Resource Page
  2. PATH is working with partners in Ghana, Kenya, Malawi, and Uganda to increase vaccine uptake and save lives.
    Published: April 2022
    Type: Article
  3. Current live, oral rotavirus vaccines (LORVs) are reducing severe diarrhea in all settings, but they are not as effective in places with the highest burden. Alternative approaches in advanced clinical development include injectable next-generation rotavirus vaccines (iNGRVs), which have the potential to better protect children against disease, be combined with existing routine immunizations, and be even more affordable than the current LORVs. PATH conducted a series of studies to understand the real public health value of iNGRVs to help inform decisions by international agencies, funders, vaccine manufacturers, and countries. This included a feasibility and acceptability study with national stakeholders and healthcare providers in Ghana, Kenya, Malawi, Peru, Senegal, and Sri Lanka to assess their preferences for different hypothetical rotavirus vaccine options. These briefs provide an overview of the results in each of the study countries.
    Published: October 2021
    Type: Resource Page
  4. Current live, oral rotavirus vaccines (LORVs) are reducing severe diarrhea in all settings, but they are not as effective in places with the highest burden. Alternative approaches in advanced clinical development include injectable next-generation rotavirus vaccines (iNGRVs), which have the potential to better protect children against disease, be combined with existing routine immunizations, and be even more affordable than the current LORVs. PATH conducted a series of studies to understand the real public health value of iNGRVs to help inform decisions by international agencies, funders, vaccine manufacturers, and countries. This included: targeted analyses on the ideal age group for iNGRVs and potential future combination vaccine options, impact and cost effectiveness analyses, a feasibility and acceptability study with national stakeholders and healthcare providers in six countries, and a demand forecast. This brief provides a comprehensive summary of the results.
    Published: October 2021
    Type: Resource Page
  5. How PATH is helping maintain access to hypertension screening and care—especially for those most at risk for severe COVID-19 illness.
    Published: August 2021
    Type: Article
  6. Robust policy is critical to achieving improved health outcomes—but far too often, action stops once a policy is developed and adopted. Policies are only as effective as the extent to which they are implemented, and poor policy implementation holds back efforts to expand equitable access to health services. To translate goals into meaningful outcomes, every policy needs a plan of action, resources, dissemination, and adaptation. That is why PATH, supported by the Bill & Melinda Gates Foundation, launched the Capital to Clinic (C2C) initiative to examine bottlenecks to policy implementation and create tools to help advocates usher policies from development in national capitals to implementation in local clinics.This white paper, a key output of the C2C initiative, is informed by key takeaways from consultations with policymakers and advocates as well as the literature on policy implementation science. It seeks to better understand policy implementation by outlining existing frameworks from the literature and examining facilitators and barriers to policy implementation in two case studies—the Community-based Health Planning and Services (CHPS) policy in Ghana and the Community Health Extension Program (HEP) in Ethiopia.
    Published: July 2021
    Type: Resource Page
  7. Together with over 400 external stakeholders from across 50 countries, PATH has crafted a new institutional strategy that responds to the current crises we face as a global community, to the needs and priorities of our local partners, and to the resounding calls for the continued transformation of our sector. To bring our new strategy to life for our external partners, we’ve developed a strategy brochure. The brochure explains why PATH exists (our mission), what we will do (our priorities) and, perhaps most importantly, how we will do it (our change strategies).
    Published: June 2021
    Type: Resource Page
  8. This set of two user personas was developed to inform service delivery strategy and development of new preeclampsia diagnostic tools, including digital tools, and explore perceptions related to taskshifting to self-monitoring. These personas focus on community health nurses (CHNs) and midwives, who have complementary roles and challenges in providing antenatal care (ANC) to their communities in Ghana, such as lack of supplies and limited infrastructure. Specifically, CHNs and midwives are currently responsible for diagnosis of preeclampsia and other pregnancy complications. Preeclampsia can be life-threatening to both the mother and child if care is delayed or complications advance to eclampsia; however, the condition can be managed and prevented with adequate diagnosis and care.This human-centered design approach focuses user needs to inform product design and delivery strategies and was developed by PATH using a two-phased process. First, draft personas were created based on a usability study conducted by PATH and the Kintampo Health Research Centre in 2016. Observational and interview data were collected from midwives (n=8) and CHNs (n=10) from 11 different health facilities in the Kintampo North and South districts of the Brong-Ahafo Region. Results were validated and refined through secondary research and a follow-on study in 2020 that engaged additional midwives (n=15) and CHNs (n=5) from 19 facilities in the same two districts in focus group discussions and interviews.
    Published: June 2021
    Type: Resource Page
  9. This report details the findings from the 2020 NCD Navigator data collection in Ghana and Kenya. The NCD Navigator is a first-of-its-kind, locally managed, NCD digital information system that provides information on NCD programming in a country. Stakeholders can use the NCD Navigator to explore active NCD initiatives in a country, establish a common understanding of gaps, work collectively to avoid duplication, and seize opportunities to better meet the needs of people living with NCDs.
    Published: March 2021
    Type: Resource Page
  10. A reliable supply chain is often referred to as the “backbone” of a health system. In addition to meeting the demand for drugs and medical supplies, it serves to safeguard a country’s investments in health commodities, which is particularly important as countries ramp up efforts to work toward universal health coverage.The aim of this Journey of the Pill assessment is to identify strengths and inefficiencies in the supply chain in Ghana. It builds on PATH’s earlier supply chain assessment in Kenya. Further defining the journey of medicines will help inform the Ministry of Health and other stakeholders of future actions to strengthen commodity security for noncommunicable diseases.
    Published: November 2020
    Type: Resource Page
Load more